Research progress in thyroid cancer stem cells

doi:10.3969/j.issn.1009-976X.2013.05.027

Abstract

Abstract: 【Abstract】Cancer stem cells are regarded as the root cause of tumorigenesis. It is a key role in tumorigenesis, metastasis, recurrence and treatment. Many studies have confirmed that the thyroid carcinoma originated from thyroid cancer stem cells. Thyroid cancer stem cells are primarily identified through its specific markers. Suppression thyroid cancer stem cells is a new method to treat thyroid carcinoma.

Key words: Thyroid cancer, Stem cells, Markers

摘要： 【摘要】肿瘤干细胞被认为是肿瘤产生的根源,对肿瘤的发生、转移、复发及治疗具有关键作用。很多研究证实甲状腺癌起源于甲状腺癌干细胞,目前主要通过特定的标记物来鉴定甲状腺癌干细胞,运用遏制甲状腺癌干细胞是治疗甲状腺癌新方法。

关键词: 甲状腺癌, 干细胞, 标记物

CLC Number:

R736.1

Xing Yue, Li Honghao. Research progress in thyroid cancer stem cells[J]. Lingnan Modern Clinics in Surgery, 2013, 13(05): 458-460.

邢越黎洪浩. 甲状腺癌干细胞研究进展[J]. 岭南现代临床外科, 2013, 13(05): 458-460.

References

1.Clevers H: The cancer stem cell: premises, promises and challenges. Nature medicine 2011:313-319.
2.Visvader JE: Cells of origin in cancer. Nature 2011, 469(7330):314-322.
3.Deonarain MP, Kousparou CA, Epenetos AA: Antibodies targeting cancer stem cells: A new paradigm in immunotherapy? In: MAbs: 2009: Landes Bioscience; 2009: 12-25.
4.Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature medicine 1997, 3(7):730-737.
5.Baumann U, Crosby HA, Ramani P, Kelly DA, Strain AJ: Expression of the stem cell factor receptor c‐kit in normal and diseased pediatric liver: Identification of a human hepatic progenitor cell? Hepatology 2003, 30(1):112-117.
6.Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences 2003, 100(7):3983-3988.
7.Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer research 2005, 65(23):10946-10951.
8.Kondo T, Ezzat S, Asa SL: Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nature Reviews Cancer 2006, 6(4):292-306.
9.Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V, Yamashita S: Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 2007, 148(4):1797-1803.
10.Lin RY: Thyroid cancer stem cells. Nature Reviews Endocrinology 2011, 7(10):609-616.
11.Zito G, Richiusa P, Bommarito A, Carissimi E, Russo L, Coppola A, Zerilli M, Rodolico V, Criscimanna A, Amato M: In vitro identification and characterization of CD133pos cancer stem-like cells in anaplastic thyroid carcinoma cell lines. PloS one 2008, 3(10):e3544.
12.Friedman S, Lu M, Schultz A, Thomas D, Lin RY: CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PloS one 2009, 4(4):e5395.
13.Ke CC, Liu RS, Yang AH, Liu CS, Chi CW, Tseng LM, Tsai YF, Ho JH, Lee CH, Lee OK: CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy. European Journal of Nuclear Medicine and Molecular Imaging 2012:1-11.
14.Tseng LM, Huang PI, Chen YR, Chen YC, Chou YC, Chen YW, Chang YL, Hsu HS, Lan YT, Chen KH: Targeting Signal Transducer and Activator of Transcription 3 Pathway by Cucurbitacin I Diminishes Self-Renewing and Radiochemoresistant Abilities in Thyroid Cancer-Derived CD133+ Cells. Journal of Pharmacology and Experimental Therapeutics 2012, 341(2):410-423.
15.Zhu W, Hai T, Ye L, Cote GJ: Medullary thyroid carcinoma cell lines contain a self-renewing CD133+ population that is dependent on ret proto-oncogene activity. Journal of Clinical Endocrinology & Metabolism 2010, 95(1):439-444.
16.Todaro M, Iovino F, Eterno V, Cammareri P, Gambara G, Espina V, Gulotta G, Dieli F, Giordano S, De Maria R: Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer research 2010, 70(21):8874-8885.
17.Malaguarnera R, Frasca F, Garozzo A, Gianì F, Pandini G, Vella V, Vigneri R, Belfiore A: Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. Journal of Clinical Endocrinology & Metabolism 2011, 96(3):766-774.
18.Derwahl M: Linking stem cells to thyroid cancer. Journal of Clinical Endocrinology & Metabolism 2011, 96(3):610-613.
19.Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. 2001.
20.Zheng X, Cui D, Xu S, Brabant G, Derwahl M: Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. International journal of oncology 2010, 37(2):307.
21.Chen G, Xu S, Renko K, Derwahl M: Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents. Journal of Clinical Endocrinology & Metabolism 2012, 97(4):E510-E520.

[1]	ZHANG Yang-yi, DING Luo-zhou, LUO Hong-li, LIU Ce, REN Jia, MA Sheng-hui. Exploration of the effect of applying nanocarbon suspension injection in thyroid cancer surgery [J]. Lingnan Modern Clinics In Surgery, 2024, 24(03): 183-186.
[2]	XU Dao-hui, LIN Liang-yu. Analysis of the predictive value of serum follicle-stimulating hormone combined with thyroglobulin for recurrence after radical surgery in patients with thyroid cancer [J]. Lingnan Modern Clinics In Surgery, 2023, 23(06): 498-503.
[3]	ZHAO Wei, LUO Man-Li. Studying the effect of Pin1-interacting lncPIL-1 on the malignant phenotypes of breast cancer cells [J]. Lingnan Modern Clinics In Surgery, 2022, 22(02): 126-133.
[4]	WU Yi, LIU Fu-ning, YAN Ying-zhe, YANG Hao-jie, XIE Qian. Lidocaine suppresses thyroid cancer cell TPC-1 proliferation via inhibiting activation of ERK signaling pathway [J]. Lingnan Modern Clinics In Surgery, 2021, 21(03): 294-297.
[5]	ZENG Di-fan, ZHONG Mei, LI Wei, WANG Qi-you. Bone marrow mesenchymal stem cell-derived exosomes treat sciatic nerve injury recovery by promoting axonal regeneration [J]. Lingnan Modern Clinics In Surgery, 2021, 21(02): 182-187.
[6]	YAO Qing-hai, LIU Bao-long. Research of pathophysiological and biochemical markers in traumatic brain injury [J]. Lingnan Modern Clinics in Surgery, 2020, 20(05): 642-649.
[7]	LIU Xiang-mei, XU Wei-guo. Multifunctional mechanism of neuropilins in tumor [J]. Lingnan Modern Clinics in Surgery, 2020, 20(04): 540-544.
[8]	WU Yao-hao, LIU Bao-ning,CHEN Lu-ping, ZENG Le-xiang, QIU Rong-lin, ZHANG Jie, SU Jian-hang, LIAO Min-yi, ZHOU Jun, DENG Xiao-geng. A preliminary study on the transdifferentiation of adipose-derived stem cells into enteric nerve-like stem cells [J]. Lingnan Modern Clinics in Surgery, 2020, 20(02): 146-150.
[9]	LI Peng, LIU Jun, WANG Dong-lai, HAN Bin, WEI Wei. Diagnosis and treatment of familial adenomatous polyposis with multifocal thyroid cancer as a parenteral manifestation [J]. Lingnan Modern Clinics in Surgery, 2020, 20(01): 113-115.
[10]	LI Zhaofeng， WANG Peng， XIE Zhongyu， CEN Shuizhong， LI Jinteng， SHEN Huiyong. Regulation of TLN1-PI3K/AKT pathway on the osteogenic differentiation of mesenchymal stem cells [J]. Lingnan Modern Clinics in Surgery, 2019, 19(04): 387-391.
[11]	HAN Bin， WANG Donglai， LI Peng， ZHU Lizhang， WEI Wei. Transoral endoscopic radical thyroidectomy via vestibular route： A report of 36 cases [J]. Lingnan Modern Clinics in Surgery, 2019, 19(03): 285-288.
[12]	ZHANG Zhijian， MO Yanping， CHEN Chao， LI Dexiang， FU Jiyong， WU Lixuan. Effects of different doses of euthyrox suppressive therapy on glucolipid metabolism and bone metabolism after radical resection of thyroid carcinoma [J]. Lingnan Modern Clinics in Surgery, 2019, 19(02): 169-173.
[13]	LIU Congyong，ZHANG Lu，SU Feng，DENG Baoping，ZENG Kuan，YANG Yanqi. The optimal concentration of prostaglandin E1 against apoptosis of rat bone marrow mesenchymal stem cells [J]. Lingnan Modern Clinics in Surgery, 2018, 18(05): 504-508.
[14]	LIU Zhihan, XIAO Xiaolian, LIANG Weiqiang, ZHANG Jinming. The implantation of ADM to which ADSCs adhere promote the dermal reparation of expander flap [J]. Lingnan Modern Clinics in Surgery, 2018, 18(02): 155-161.
[15]	CHANG Ruiming, CHEN Jinwu, YANG Tao, WANG Peng, CHANG Jianxing. Effect of bone marrow mesenchymal stem cells on expression OPG and RANKL in the bone tis? sue in diabetic rats with peripheral neuropathy [J]. Lingnan Modern Clinics in Surgery, 2018, 18(01): 75-78.